| phv00498211.v1.p1 |
Subject_ID |
Subject ID |
pht012068.v1.p1 |
CIDR_ERNeg_BC_AA_Subject |
| phv00498212.v1.p1 |
CONSENT |
Consent group as determined by DAC |
pht012068.v1.p1 |
CIDR_ERNeg_BC_AA_Subject |
| phv00498213.v1.p1 |
SEX |
Biological sex |
pht012068.v1.p1 |
CIDR_ERNeg_BC_AA_Subject |
| phv00498214.v1.p1 |
SUBJECT_SOURCE |
Source repository where subjects originate |
pht012068.v1.p1 |
CIDR_ERNeg_BC_AA_Subject |
| phv00498215.v1.p1 |
SOURCE_SUBJECT_ID |
Subject ID used in the Source Repository |
pht012068.v1.p1 |
CIDR_ERNeg_BC_AA_Subject |
| phv00498216.v1.p1 |
SUBJECT_SOURCE2 |
Source repository where subjects originate |
pht012068.v1.p1 |
CIDR_ERNeg_BC_AA_Subject |
| phv00498217.v1.p1 |
SOURCE_SUBJECT_ID2 |
Subject ID used in the Source Repository |
pht012068.v1.p1 |
CIDR_ERNeg_BC_AA_Subject |
| phv00498218.v1.p1 |
Subject_ID |
Subject ID |
pht012069.v1.p1 |
CIDR_ERNeg_BC_AA_Sample |
| phv00498219.v1.p1 |
SAMPLE_ID |
Sample ID |
pht012069.v1.p1 |
CIDR_ERNeg_BC_AA_Sample |
| phv00498220.v1.p1 |
SAMPLE_NAME |
Unique ID for the sample |
pht012070.v1.p1 |
CIDR_ERNeg_BC_AA_Subject_Phenotypes |
| phv00498221.v1.p1 |
Subject_ID |
Unique ID for the subject |
pht012070.v1.p1 |
CIDR_ERNeg_BC_AA_Subject_Phenotypes |
| phv00498222.v1.p1 |
CASE_CONTROL |
Is the participant a case or control for breast cancer? |
pht012070.v1.p1 |
CIDR_ERNeg_BC_AA_Subject_Phenotypes |
| phv00498223.v1.p1 |
SEX |
Gender |
pht012070.v1.p1 |
CIDR_ERNeg_BC_AA_Subject_Phenotypes |
| phv00498224.v1.p1 |
AGE |
Case age at diagnsois or control age at study participation |
pht012070.v1.p1 |
CIDR_ERNeg_BC_AA_Subject_Phenotypes |
| phv00498225.v1.p1 |
ERSTAT |
Estrogen Receptor status |
pht012070.v1.p1 |
CIDR_ERNeg_BC_AA_Subject_Phenotypes |
| phv00498226.v1.p1 |
PRSTAT |
Progesterone Receptor status |
pht012070.v1.p1 |
CIDR_ERNeg_BC_AA_Subject_Phenotypes |
| phv00498227.v1.p1 |
HER2STAT |
Human Epidermal Growth Factor Receptor 2 status |
pht012070.v1.p1 |
CIDR_ERNeg_BC_AA_Subject_Phenotypes |
| phv00498228.v1.p1 |
STAGE |
Breast cancer stage at diagnosis |
pht012070.v1.p1 |
CIDR_ERNeg_BC_AA_Subject_Phenotypes |
| phv00498229.v1.p1 |
SAMPLE_ID |
Sample ID |
pht012071.v1.p1 |
CIDR_ERNeg_BC_AA_Sample_Attributes |
| phv00498230.v1.p1 |
BODY_SITE |
Body site where sample was collected |
pht012071.v1.p1 |
CIDR_ERNeg_BC_AA_Sample_Attributes |
| phv00498231.v1.p1 |
ANALYTE_TYPE |
Analyte Type |
pht012071.v1.p1 |
CIDR_ERNeg_BC_AA_Sample_Attributes |
| phv00498232.v1.p1 |
IS_TUMOR |
Tumor status |
pht012071.v1.p1 |
CIDR_ERNeg_BC_AA_Sample_Attributes |